Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sindbis Virus | 12 | 2010 | 14 | 1.630 |
Why?
|
| Viral Envelope Proteins | 10 | 2005 | 90 | 0.680 |
Why?
|
| Genetic Vectors | 6 | 2009 | 165 | 0.560 |
Why?
|
| Viral Matrix Proteins | 1 | 2017 | 18 | 0.550 |
Why?
|
| Influenza A virus | 1 | 2017 | 31 | 0.540 |
Why?
|
| Influenza Vaccines | 1 | 2017 | 55 | 0.520 |
Why?
|
| Influenza, Human | 1 | 2017 | 90 | 0.510 |
Why?
|
| Bluetongue virus | 9 | 1993 | 11 | 0.440 |
Why?
|
| Viral Proteins | 4 | 2010 | 196 | 0.370 |
Why?
|
| Cricetinae | 12 | 2010 | 241 | 0.360 |
Why?
|
| Furin | 2 | 2010 | 6 | 0.330 |
Why?
|
| Virus Replication | 3 | 2010 | 318 | 0.300 |
Why?
|
| Drosophila Proteins | 1 | 2010 | 183 | 0.280 |
Why?
|
| Culicidae | 3 | 2010 | 26 | 0.280 |
Why?
|
| Reoviridae | 5 | 1990 | 7 | 0.280 |
Why?
|
| Virion | 5 | 2000 | 73 | 0.250 |
Why?
|
| Bluetongue | 8 | 1993 | 11 | 0.250 |
Why?
|
| Receptors, Fc | 1 | 2005 | 7 | 0.240 |
Why?
|
| Viral Structural Proteins | 2 | 2003 | 17 | 0.230 |
Why?
|
| Animals | 28 | 2017 | 16695 | 0.220 |
Why?
|
| Cell Line | 12 | 2014 | 1416 | 0.220 |
Why?
|
| Antibodies, Viral | 4 | 2017 | 295 | 0.210 |
Why?
|
| Polyproteins | 1 | 2003 | 3 | 0.200 |
Why?
|
| Membrane Glycoproteins | 3 | 2004 | 221 | 0.190 |
Why?
|
| Cattle Diseases | 4 | 1990 | 30 | 0.190 |
Why?
|
| Oligosaccharides | 1 | 2000 | 28 | 0.160 |
Why?
|
| CHO Cells | 4 | 2010 | 123 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 3 | 2017 | 686 | 0.150 |
Why?
|
| Mice | 8 | 2017 | 6490 | 0.150 |
Why?
|
| Arterivirus Infections | 3 | 2007 | 3 | 0.150 |
Why?
|
| Horse Diseases | 3 | 2007 | 11 | 0.150 |
Why?
|
| Molecular Sequence Data | 7 | 2007 | 1559 | 0.150 |
Why?
|
| Protein Precursors | 2 | 1999 | 59 | 0.140 |
Why?
|
| Alphavirus | 1 | 2017 | 10 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 2 | 1996 | 184 | 0.140 |
Why?
|
| Amino Acid Sequence | 5 | 2005 | 1188 | 0.130 |
Why?
|
| Vaccination | 2 | 2017 | 332 | 0.130 |
Why?
|
| Virulence | 5 | 2003 | 238 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 6 | 2004 | 301 | 0.120 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2014 | 6 | 0.110 |
Why?
|
| Flagellin | 1 | 2014 | 18 | 0.110 |
Why?
|
| Suppression, Genetic | 1 | 1994 | 6 | 0.110 |
Why?
|
| Antigens, Viral | 2 | 1992 | 50 | 0.110 |
Why?
|
| Tularemia | 1 | 2014 | 115 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2005 | 293 | 0.100 |
Why?
|
| Bacterial Vaccines | 1 | 2014 | 129 | 0.100 |
Why?
|
| RNA, Double-Stranded | 2 | 1989 | 23 | 0.100 |
Why?
|
| Animals, Newborn | 3 | 2003 | 350 | 0.090 |
Why?
|
| Cattle | 8 | 2002 | 505 | 0.080 |
Why?
|
| Epitopes | 5 | 2004 | 155 | 0.080 |
Why?
|
| Anthrax Vaccines | 1 | 2009 | 1 | 0.080 |
Why?
|
| Ciprofloxacin | 1 | 2009 | 16 | 0.080 |
Why?
|
| Cricetulus | 1 | 2010 | 82 | 0.080 |
Why?
|
| Anthrax | 1 | 2009 | 18 | 0.080 |
Why?
|
| Oligonucleotides | 1 | 1989 | 54 | 0.080 |
Why?
|
| Bacillus anthracis | 1 | 2009 | 33 | 0.080 |
Why?
|
| Vaccines, Synthetic | 2 | 2009 | 78 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2010 | 217 | 0.080 |
Why?
|
| Bacterial Toxins | 1 | 2009 | 50 | 0.080 |
Why?
|
| Mutation | 4 | 2000 | 1169 | 0.080 |
Why?
|
| Neutralization Tests | 6 | 2004 | 55 | 0.080 |
Why?
|
| Drosophila | 1 | 2010 | 150 | 0.070 |
Why?
|
| Viral Core Proteins | 2 | 2003 | 13 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2007 | 195 | 0.070 |
Why?
|
| Antigens, Bacterial | 1 | 2009 | 144 | 0.070 |
Why?
|
| Binding Sites | 3 | 2005 | 670 | 0.070 |
Why?
|
| Gene Frequency | 1 | 1988 | 203 | 0.070 |
Why?
|
| Aedes | 2 | 2000 | 42 | 0.070 |
Why?
|
| Glycosylation | 2 | 2000 | 111 | 0.070 |
Why?
|
| Vaccines, Attenuated | 2 | 2014 | 75 | 0.070 |
Why?
|
| Genome, Viral | 1 | 2007 | 118 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 415 | 0.060 |
Why?
|
| BALB 3T3 Cells | 1 | 2005 | 2 | 0.060 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2005 | 9 | 0.060 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2005 | 22 | 0.060 |
Why?
|
| Phenotype | 3 | 2000 | 774 | 0.060 |
Why?
|
| Replicon | 2 | 2002 | 7 | 0.050 |
Why?
|
| Encephalitis Virus, Venezuelan Equine | 2 | 2002 | 11 | 0.050 |
Why?
|
| Vaccines, DNA | 2 | 2002 | 24 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 65 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 207 | 0.050 |
Why?
|
| Antibodies, Bacterial | 2 | 2014 | 117 | 0.050 |
Why?
|
| Humans | 4 | 2017 | 42163 | 0.040 |
Why?
|
| Nucleotide Mapping | 2 | 1991 | 2 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2000 | 158 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2005 | 580 | 0.040 |
Why?
|
| Viremia | 3 | 2007 | 44 | 0.040 |
Why?
|
| Mannosidases | 1 | 2000 | 2 | 0.040 |
Why?
|
| 1-Deoxynojirimycin | 1 | 2000 | 3 | 0.040 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2000 | 14 | 0.040 |
Why?
|
| Ultracentrifugation | 1 | 2000 | 14 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 189 | 0.040 |
Why?
|
| Subtilisins | 1 | 1999 | 12 | 0.040 |
Why?
|
| Heparitin Sulfate | 1 | 1999 | 23 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 1999 | 22 | 0.040 |
Why?
|
| Horses | 3 | 2007 | 28 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 1989 | 78 | 0.040 |
Why?
|
| Precipitin Tests | 4 | 1993 | 51 | 0.040 |
Why?
|
| Female | 2 | 2017 | 24018 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2000 | 189 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1999 | 454 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 457 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2009 | 253 | 0.030 |
Why?
|
| Sheep | 3 | 1992 | 77 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1996 | 20 | 0.030 |
Why?
|
| Goats | 2 | 1992 | 22 | 0.030 |
Why?
|
| Deer | 2 | 1992 | 16 | 0.030 |
Why?
|
| Capsid | 2 | 1993 | 64 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 256 | 0.030 |
Why?
|
| Transfection | 1 | 1994 | 526 | 0.030 |
Why?
|
| Francisella tularensis | 1 | 2014 | 116 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 387 | 0.020 |
Why?
|
| Ruminants | 1 | 1992 | 7 | 0.020 |
Why?
|
| Recombination, Genetic | 2 | 2004 | 96 | 0.020 |
Why?
|
| Kidney | 1 | 1994 | 363 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1994 | 508 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 1996 | 1617 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1994 | 599 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1991 | 64 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 71 | 0.020 |
Why?
|
| Vero Cells | 1 | 1991 | 109 | 0.020 |
Why?
|
| Viral Vaccines | 2 | 2002 | 36 | 0.020 |
Why?
|
| DNA, Viral | 2 | 2007 | 323 | 0.020 |
Why?
|
| Blood Cells | 1 | 1990 | 8 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1990 | 107 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 67 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 515 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 1990 | 73 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1990 | 86 | 0.020 |
Why?
|
| Thymus Gland | 1 | 1990 | 74 | 0.020 |
Why?
|
| Spleen | 1 | 1990 | 199 | 0.020 |
Why?
|
| Hybridomas | 1 | 1988 | 24 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1988 | 21 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1991 | 429 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2009 | 118 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 362 | 0.020 |
Why?
|
| Borrelia | 1 | 1988 | 4 | 0.020 |
Why?
|
| Lyme Disease | 1 | 1988 | 25 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 1990 | 928 | 0.020 |
Why?
|
| Dog Diseases | 1 | 1988 | 48 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1987 | 75 | 0.020 |
Why?
|
| Virus Shedding | 1 | 2007 | 9 | 0.020 |
Why?
|
| Monocytes | 1 | 1989 | 275 | 0.020 |
Why?
|
| RNA, Viral | 1 | 1988 | 317 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 247 | 0.020 |
Why?
|
| Immune Sera | 1 | 2004 | 56 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2004 | 81 | 0.010 |
Why?
|
| Time Factors | 1 | 1988 | 1848 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2004 | 273 | 0.010 |
Why?
|
| Species Specificity | 1 | 2004 | 279 | 0.010 |
Why?
|
| Serotyping | 2 | 1993 | 37 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 427 | 0.010 |
Why?
|
| Dimerization | 1 | 2000 | 115 | 0.010 |
Why?
|
| Immunization | 1 | 2000 | 93 | 0.010 |
Why?
|
| Heparin Lyase | 1 | 1999 | 2 | 0.010 |
Why?
|
| Sepharose | 1 | 1999 | 17 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 1999 | 49 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 292 | 0.010 |
Why?
|
| Antibody Specificity | 2 | 1989 | 76 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 318 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1988 | 198 | 0.010 |
Why?
|
| Virus Assembly | 1 | 1998 | 44 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1999 | 400 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1998 | 127 | 0.010 |
Why?
|
| Alphavirus Infections | 1 | 1996 | 7 | 0.010 |
Why?
|
| Arginine | 1 | 1996 | 75 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 997 | 0.010 |
Why?
|
| Male | 3 | 2002 | 22779 | 0.010 |
Why?
|
| Capsid Proteins | 1 | 1993 | 74 | 0.010 |
Why?
|
| Antigenic Variation | 1 | 1992 | 8 | 0.010 |
Why?
|
| United States | 2 | 1993 | 5072 | 0.010 |
Why?
|
| Autoradiography | 1 | 1989 | 35 | 0.000 |
Why?
|
| Sulfur Radioisotopes | 1 | 1988 | 7 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1989 | 196 | 0.000 |
Why?
|
| Wisconsin | 1 | 1988 | 5 | 0.000 |
Why?
|
| Connecticut | 1 | 1988 | 11 | 0.000 |
Why?
|
| Maryland | 1 | 1988 | 61 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1989 | 411 | 0.000 |
Why?
|
| North Carolina | 1 | 1988 | 122 | 0.000 |
Why?
|
| Immunoassay | 1 | 1988 | 69 | 0.000 |
Why?
|
| Dogs | 1 | 1988 | 201 | 0.000 |
Why?
|